According to the sources provided, there is no current information regarding any Lipitor promotions.

The first source, Drug Patent Watch [1], provides information on the expiration of the patent for Lipitor, which occurred in 2011. Since then, there have been no updates on any promotions for the drug.

The second source, an article from the Journal of Ethics [2], discusses the importance of authenticity and uniqueness in pharmaceuticals and uses Lipitor as an example. However, there is no mention of any current promotions for the drug.

The third source, a study published in JAMA Internal Medicine [3], focuses on the effectiveness of statin therapy, including Lipitor, in preventing cardiovascular disease. While the study provides valuable information on the benefits of Lipitor, it does not mention any current promotions for the drug.

In conclusion, based on the sources provided, there is no information on any current promotions for Lipitor. It is important to consult with a healthcare professional before taking any medication.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] https://journalofethics.ama-assn.org/article/me-there-no-substitute-authenticity-uniqueness-and-lessons-lipitor/2010-10
[3] https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/773513